Selection of Optimal Antisense Accessible Sites of Uroplakin Ⅱ mRNA for Bladder Urothelium

Liduan ZHENG,Qiangsong TONG,Fangmin CHEN,Fuqing ZENG,Liang WANG,Jihua DONG

2009-01-01

Abstract:The optimal antisense accessible sites (AAS) of uroplakin Ⅱ (UPⅡ) mRNA, a specific gene expressed in bladder urothelium, were selected in order to provide a novel method for targeted therapy of transitional cell carcinoma (TCC) of bladder. The 20 mer random oligonucleotide library was synthesized, hybridized with in vitro transcripted total UPⅡ cRNA, then digested by RNase H. After primer extension and autoradiography, the AAS of UPⅡ were selected. The RNADraw soft-ware was used to analyze and choose the AAS with obvious stem-loop structures, according to which the complementary antisense oligonucleotides (AS-ODN) were synthesized. With the AS-ODN0 de-signed only by RNADraw as a control, the AS-ODNs were transferred into UPⅡ highly-expressing cell line RT4. The cellular expression of UPⅡ mRNA was detected by RT-PCR and Western blot. Twelve AAS of UPⅡ mRNA were selected in vitro. Four AAS with stem-loop structures were cho-sen, locating at 558—577, 552—571, 217—236 and 97—116 bp of UPⅡ mRNA respectively. After transfection with the corresponding AS-ODN (AS-ODN1, AS-ODN2, AS-ODN3 and AS-ODN4) for 18 h, the UPⅡ mRNA levels in RT4 cells were reduced by 29.3%, 82.7%, 71.3% and 70.9%, while UPⅡ protein levels were decreased by 20.2%, 78.5%, 65.2% and 64.4% respectively, which were significantly higher than those of AS-ODN0 (14.3%, 12.1% respectively) (P<0.01). The AAS of UPⅡ mRNA was effectively selected in vitro by random oligonucletide library/RNase H cleavage method in combination with computer software analysis, which had important reference values for further studying biological functions of UPⅡ gene and targeted therapeutic strategy for TCC of bladder.